© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 16, 1187-1188,
August 21, 2002
© 2002 Oxford University Press
EDITORIAL |
St. John's Wort: More Implications for Cancer Patients
Affiliation of authors: P. J. Mansky, S. E. Straus, National Center for Complementary and Alternative Medicine, National Institutes of Health, Bethesda, MD.
Correspondence to: Stephen E. Straus, M.D., Director, NCCAM/NIH, Bldg. 31, Rm. 2B-11, 31 Center Dr., Bethesda, MD 20892 (e-mail: sstraus@nih.gov).
| The first 10% of the full text of this article appears below. |
St. John's wort (Hypericum perforatum L.) has been used as a medicinal plant in Europe and Asia for centuries. Although it is best known today for its use by patients with mild to moderately severe depression, St. John's wort has also been used orally as a traditional treatment for excitability, neuralgia, fibrositis, sciatica, and anxiety and as a topical preparation for the treatment of wounds (1). Concerns over its use have been raised with the recognition that, whatever its beneficial health effects might be, St. John's wort interacts powerfully with many important drugs, potentially mitigating their effects (1)
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. J. Hlubocky, M. J. Ratain, M. Wen, and C. K. Daugherty Complementary and Alternative Medicine Among Advanced Cancer Patients Enrolled on Phase I Trials: A Study of Prognosis, Quality of Life, and Preferences for Decision Making J. Clin. Oncol., February 10, 2007; 25(5): 548 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503. [Abstract] [Full Text] [PDF] |
||||
